- Home
- CARV vs CHRO Comparison
CARV vs CHRO Comparison
Compare CARV & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- CHRO
- Stock Information
- Founded
- CARV 1948
- CHRO 2002
- Country
- CARV United States
- CHRO United States
- Employees
- CARV N/A
- CHRO N/A
- Industry
- CARV Savings Institutions
- CHRO
- Sector
- CARV Finance
- CHRO
- Exchange
- CARV Nasdaq
- CHRO Nasdaq
- Market Cap
- CARV 7.2M
- CHRO 8.4M
- IPO Year
- CARV 1994
- CHRO 2024
- Fundamental
- Price
- CARV $1.37
- CHRO $1.00
- Analyst Decision
- CARV
- CHRO Strong Buy
- Analyst Count
- CARV 0
- CHRO 1
- Target Price
- CARV N/A
- CHRO N/A
- AVG Volume (30 Days)
- CARV 14.0K
- CHRO 157.9K
- Earning Date
- CARV 02-13-2025
- CHRO 05-13-2025
- Dividend Yield
- CARV N/A
- CHRO N/A
- EPS Growth
- CARV N/A
- CHRO N/A
- EPS
- CARV N/A
- CHRO N/A
- Revenue
- CARV $24,056,000.00
- CHRO N/A
- Revenue This Year
- CARV N/A
- CHRO N/A
- Revenue Next Year
- CARV N/A
- CHRO N/A
- P/E Ratio
- CARV N/A
- CHRO N/A
- Revenue Growth
- CARV N/A
- CHRO N/A
- 52 Week Low
- CARV $1.30
- CHRO $0.45
- 52 Week High
- CARV $2.39
- CHRO $3.80
- Technical
- Relative Strength Index (RSI)
- CARV 47.92
- CHRO 37.31
- Support Level
- CARV $1.30
- CHRO $0.91
- Resistance Level
- CARV $1.47
- CHRO $1.14
- Average True Range (ATR)
- CARV 0.08
- CHRO 0.13
- MACD
- CARV 0.01
- CHRO -0.01
- Stochastic Oscillator
- CARV 38.89
- CHRO 19.15
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.